跳至主要内容
临床试验/ITMCTR2200006038
ITMCTR2200006038招募中4 期

Randomized controlled prospective study on treatment of mild COVID-19 with Qinghua Bihui Granules

Jiujiang Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • The mild diagnosis of COVID-19 in accordance with the Novel Coronavirus Diagnosis and Treatment Protocol for Pneumonia (Trial Version 9) published by the NHC; The patient was older than 18 years; Signed informed consent.

排除标准

  • Pregnant and lactating women; Patients allergic to Chinese medicine or allergic constitution of this project; Patients with malignant tumor, liver cirrhosis, chronic renal failure (uremic stage), blood system diseases, HIV and other serious underlying diseases; Patients with long-term use of hormones, immunosuppressants and other drugs; Who suffered from severe mental illness or were unable to cooperate with the study.

研究者

相似试验